Randomized placebo-controlled trial of intrathecal clot lysis to reduce vasospasm in aneurysmal subarachnoid hemorrhage

JIPMER PUDUCHERRY0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients who are diagnosed with subarachnoid hemorrhage due to an aneurysmal rupture diagnosed with appropriate imaging methods like CT scan, CT angiography, MRI, MR angiography, and Digital Subtraction Angiography (DSA) and who have undergone treatment of the ruptured aneurysm, typically by microsurgical clipping or coiling.

•Remote subarachnoid hemorrhage (more than 14 days of aneurysmal rupture) where either the vasospasm has already set in or is likely to have disappeared.
•Patients who have already developed severe vasospasm (Mean velocities of the MCA of 200 cm/sec or greater indicate severe spasm and correlate with 50% or greater narrowing on angiogram) detected by any imaging method or have already suffered delayed neurological deficits.
•Patients in whom the ruptured aneurysm could not be fully secured by microsurgical clipping or endovascular coiling.
•Spontaneously thrombosed aneurysms will also be excluded.

发起方